Busulfan and cyclophosphamide as conditioning regimen for autologous BMT in acute lymphoblastic leukemia
Porcellini, A.; Manna, A.; Moretti, L.; Carotenuto, M.; Greco, M.M.; Bodenizza, C.
Bone Marrow Transplantation 4(3): 331-333
1989
ISSN/ISBN: 0268-3369 PMID: 2659120 Document Number: 338907
Document emailed within 1 workday
Related Documents
Russell, S.; Vowels, M. 1992: Busulphan, cyclophosphamide, and melphalan as conditioning therapy in allogeneic bone marrow transplants for acute lymphoblastic leukemia Transplantation Proceedings 24(1): 183Nagatoshi, Y.; Okamura, J.; Ikuno, Y.; Akamatsu, M.; Tasaka, H. 1997: Therapeutic trial of intensified conditioning regimen with high-dose cytosine arabinoside, cyclophosphamide and either total body irradiation or busulfan followed by allogeneic bone marrow transplantation for myelodysplastic syndrome in children International Journal of Hematology 65(3): 269-275
Takami, A.; Chuhjo, T.; Nakao, S. 2002: Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen Haematologica 87(6): 659-661
Shepherd, J.D.; Hoar, D.I.; Keown, P.A.; Phillips, G.L. 1996: Successful paternity of twins following bone marrow transplantation with busulfan, melphalan and cyclophosphamide conditioning Bone Marrow Transplantation 17(3): 461-462
Tutschka, P.J. 1993: Use of busulfan containing chemotherapy for conditioning patients with leukemia for bone marrow allografting Bone Marrow Transplantation 12(Suppl 1): 34-36
Koller, C.A.; Kantarjian, H.M.; Thomas, D.; O'Brien, S.; Rios, M.B.; Kornblau, S.; Murphy, S.; Keating, M. 1997: The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia Leukemia 11(12): 2039-2044
Doney, K.; Buckner, C.D.; Fisher, L.; Petersen, F.B.; Sanders, J.; Appelbaum, F.R.; Anasetti, C.; Badger, C.; Bensinger, W.; Deeg, H.J. 1993: Autologous bone marrow transplantation for acute lymphoblastic leukemia Bone Marrow Transplantation 12(4): 315-321
Weyman, C.; Graham-Pole, J.; Emerson, S.; August, C.; Champlin, R.; Coccia, P.; Fay, J.; Harris, R.; Koch, P.; Johnson, L. 1993: Use of cytosine arabinoside and total body irradiation as conditioning for allogeneic marrow transplantation in patients with acute lymphoblastic leukemia: a multicenter survey Bone Marrow Transplantation 11(1): 43-50
Granados, E.; de La Cámara, R.; Madero, L.; Díaz, M.A.; Martín-Regueira, P.; Steegmann, J.L.; Arranz, R.; Figuera, A.; Fernández-Rañada, J.M. 2000: Hematopoietic cell transplantation in acute lymphoblastic leukemia: better long term event-free survival with conditioning regimens containing total body irradiation Haematologica 85(10): 1060-1067
Sureda, A.; Canals, C.; Badell, I.; Nomdedeu, J.; Llácer, M.; Brunet, S.; Sierra, J.; Grañena, A.; Cubells, J.; Domingo-Albós, A. 1992: GM-CSF administration enhances granulocytic recovery in purged autologous bone marrow transplantation for acute lymphoblastic leukemia Progress in Clinical and Biological Research 377: 315-320
Skala, J.P.; Rogers, P.C.; Chan, K.W.; Rodriguez, W.C. 1992: Effect of Ethiofos on cytotoxicity of pharmacological purging protocols used for autologous marrow grafts in acute lymphoblastic leukemia Progress in Clinical and Biological Research 377: 57-62
Soiffer, R.J.; Roy, D.C.; Gonin, R.; Murray, C.; Anderson, K.C.; Freedman, A.S.; Rabinowe, S.N.; Robertson, M.J.; Spector, N.; Pesek, K. 1993: Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse Bone Marrow Transplantation 12(3): 243-251
Mazza, P.; Amurri, B.; Palazzo, G.; Prudenzano, A.; Pricolo, G.; Stani, L. 2000: Fludarabine containing regimen followed by autologous peripheral blood stem cell transplantation in unselected patients with acute myeloid leukemia: a single center experience Haematologica 85(2): 222-224
Koehler, M.; Bubała, H.; Hałatek, M. 1988: Infections in children during treatment of acute lymphoblastic leukemia according to Riehm's regimen. analysis of material from the I pediatric clinic of the Silesian Medical Academy in Zabrze from 1982-1986 Pediatria Polska 63(12): 771-776
Bregni, M.; Siena, S.; Subar, M.; Villa, S.; Bonadonna, G.; Dalla-Favera, R.; Gianni, A.M. 1989: Detection of occult leukemic cells in the autologous bone marrow graft of a patient with T-cell acute lymphoblastic leukemia by a highly specific and sensitive assay Haematologica 74(1): 11-14
Powles, R.; Mehta, J.; Singhal, S.; Horton, C.; Tait, D.; Milan, S.; Pollard, C.; Lumley, H.; Matthey, F.; Shirley, J. 1995: Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center Bone Marrow Transplantation 16(2): 241-247
Cervantes, F.; Rozman, C.; Nomdedeu, B.; Blade, J.; Montserrat, E. 1986: Chronic myeloid leukemia: comparison of monotherapy with busulfan with busulfan and vincristine and 6-mercaptopurine cycles Revista Clinica Espanola 178(1): 4-7
Taguchi, T.; Sakai, K.; Terasawa, T.; Wada, H. 1986: Results of clinical trials with a CMitF (cyclophosphamide, mitoxantrone, and 5-fluorouracil) regimen versus a CAF (cyclophosphamide, adriamycin, and 5-fluorouracil) regimen in advanced/relapsed breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(9): 2820-2828
Schmid, H.; Henze, G.; Schwerdtfeger, R.; Baumgarten, E.; Besserer, A.; Scheffler, A.; Serke, S.; Zingsem, J.; Siegert, W. 1993: Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia Bone Marrow Transplantation 12(6): 597-602
Canals, C.; Picón, M.; Sanchez, T.; Torrico, C.; Amill, B.; Tugues, D.; Sierra, J.; Grañena, A.; Badell, I.; Brunet, S. 1994: Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging Progress in Clinical and Biological Research 389: 125-132